NC
ABBV icon

Nexthera Capital’s AbbVie ABBV Stock Holding History

Nexthera Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$3.83M Buy
+52,681
New +$4.14M 3.19% 14
2016
Q1 		– Sell
-61,500
Closed -$3.64M – 33
2015
Q4 		$3.64M Buy
+61,500
New +$3.54M 5.17% 6

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Nexthera Capital's ABBV Position: Q2 2019 in Review

Nexthera Capital opened a new position in AbbVie (ABBV) in Q2 2019: 52,681 shares worth $3.83M. The stake represents 3.19% of the portfolio and ranks #14 among its holdings. This is a return to the name: Nexthera Capital previously reported a position in ABBV as recently as Q4 2015.

Nexthera Capital first reported a position in ABBV in Q4 2015 and has held it in 2 quarters since. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Nexthera Capital held 52,681 shares of AbbVie worth $3.83M as of Q2 2019.
  • AbbVie was a new Nexthera Capital position in Q2 2019.
  • AbbVie made up 3.19% of Nexthera Capital's portfolio in Q2 2019, its #14 holding.
  • Nexthera Capital first reported a position in AbbVie in Q4 2015 and has held it in 2 quarters since.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.